Swiss National Bank

Bank

Position in ERAS — Erasca, Inc.

CIK 1582202 ZURICH, V8

Position in ERAS

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$5,449,424

+$4,999,105 QoQ

Shares Held

336,800

+2.5% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. ERAS ranks #47 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,600	$332,493,684
2	REGN	Regeneron Pharmaceuticals, Inc.	303,140	$234,218,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	387,720	$128,284,916
4	INSM	INSMED Inc	625,912	$102,349,130
5	RPRX	Royalty Pharma plc	1,191,100	$57,137,067
6	INCY	Incyte Corp	489,774	$46,097,528
7	RVMD	Revolution Medicines, Inc.	425,431	$41,373,164
8	MRNA	Moderna, Inc.	696,100	$35,361,880

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,449,424	336,800	+2.5%	Shares	Sole	2026-05-07
2025-03-31	$450,319	328,700	-9.0%	Shares	Sole	2025-05-12
2024-12-31	$906,612	361,200	+9.6%	Shares	Sole	2025-02-10
2024-09-30	$900,081	329,700	+121.6%	Shares	Sole	2024-11-07
2023-12-31	$316,944	148,800	-18.4%	Shares	Sole	2024-02-06
2023-09-30	$359,131	182,300	+11.2%	Shares	Sole	2023-11-08
2023-06-30	$452,364	163,900	+10.3%	Shares	Sole	2023-08-09
2023-03-31	$447,286	148,600	-7.8%	Shares	Sole	2023-05-10
2022-12-31	$694,772	161,200	+125.1%	Shares	Sole	2023-02-08
2022-09-30	$558,480	71,600	0.0%	Shares	Sole	2022-11-09
2022-06-30	$398,812	71,600	+24.7%	Shares	Sole	2022-08-09
2022-03-31	$493,640	57,400	+7.5%	Shares	Sole	2022-05-09
2021-12-31	$831,972	53,400	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.